-
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trialLopes RD, Vora AN, Liaw D et al. -
Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart AssociationHayes SN, American Heart Association Council on Peripheral Vascular Disease; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; and Stroke Council.
-
Systems of Care for ST-Segment–Elevation Myocardial Infarction: A Policy Statement From the American Heart AssociationAK Jacobs, MJ Ali, , and on behalf of the American Heart Association Advocacy Coordinating Committee
-
Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4MM Liu, M Yan, D Ai et al.
-
Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent ImplantationS Kubo, A Kuwayama, T Shimada et al.
-
Cardiac Shock Care Centers: JACC Review Topic of the WeekRab T, Ratanapo S, Kern KB et al.
-
Homeostatic Chemokines and Prognosis in Patients With Acute Coronary SyndromesKC, M Hartford, A Ravn-Fischer, E Lorentzen et al.
-
Predicting Major Adverse Events in Patients With Acute Myocardial InfarctionT Nestelberger, J Boeddinghaus, the APACE Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
